Literature DB >> 24671572

State-dependent blocker interactions with the CFTR chloride channel: implications for gating the pore.

Paul Linsdell1.   

Abstract

Chloride permeation through the cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel is subject to voltage-dependent open-channel block by a diverse range of cytoplasmic anions. However, in most cases the ability of these blocking substances to influence the pore opening and closing process has not been reported. In the present work, patch clamp recording was used to investigate the state-dependent block of CFTR by cytoplasmic Pt(NO2)4(2-) ions. Two major effects of Pt(NO2)4(2-) were identified. First, this anion caused fast, voltage-dependent block of open channels, leading to an apparent decrease in single-channel current amplitude. Secondly, Pt(NO2)4(2-) also decreased channel open probability due to an increase in interburst closed times. Interestingly, mutations in the pore that weakened (K95Q) or strengthened (I344K, V345K) interactions with Pt(NO2)4(2-) altered blocker effects both on Cl(-) permeation and on channel gating, suggesting that both these effects are a consequence of Pt(NO2)4(2-) interaction with a single site within the pore. Experiments at reduced extracellular Cl(-) concentration hinted that Pt(NO2)4(2-) may have a third effect, possibly increasing channel activity by interfering with channel closure. These results suggest that Pt(NO2)4(2-) can enter from the cytoplasm into the pore inner vestibule of both open and closed CFTR channels, and that Pt(NO2)4(2-) bound in the inner vestibule blocks Cl(-) permeation as well as interfering with channel opening and, perhaps, channel closure. Implications for the location of the channel gate in the pore, and the operation of this gate, are discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24671572     DOI: 10.1007/s00424-014-1501-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  36 in total

1.  Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.

Authors:  O Moran; L J V Galietta; O Zegarra-Moran
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

2.  Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity.

Authors:  Zhiwei Cai; David N Sheppard
Journal:  J Biol Chem       Date:  2002-03-19       Impact factor: 5.157

3.  Functional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulator potentiators. Interaction between activation and inhibition.

Authors:  Olga Zegarra-Moran; Martino Monteverde; Luis J V Galietta; Oscar Moran
Journal:  J Biol Chem       Date:  2007-01-23       Impact factor: 5.157

4.  Immobilisation of gating charge by a substance that simulates inactivation.

Authors:  J Z Yeh; C M Armstrong
Journal:  Nature       Date:  1978-06-01       Impact factor: 49.962

5.  Activating cystic fibrosis transmembrane conductance regulator channels with pore blocker analogs.

Authors:  Wei Wang; Ge Li; John Paul Clancy; Kevin L Kirk
Journal:  J Biol Chem       Date:  2005-04-27       Impact factor: 5.157

6.  Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in murine cell line.

Authors:  K A Lansdell; Z Cai; J F Kidd; D N Sheppard
Journal:  J Physiol       Date:  2000-04-15       Impact factor: 5.182

7.  Physiology of epithelial chloride and fluid secretion.

Authors:  Raymond A Frizzell; John W Hanrahan
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

8.  Dual roles of the sixth transmembrane segment of the CFTR chloride channel in gating and permeation.

Authors:  Yonghong Bai; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2010-09       Impact factor: 4.086

9.  Alignment of transmembrane regions in the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Wuyang Wang; Yassine El Hiani; Paul Linsdell
Journal:  J Gen Physiol       Date:  2011-07-11       Impact factor: 4.086

10.  Structural basis for the channel function of a degraded ABC transporter, CFTR (ABCC7).

Authors:  Yonghong Bai; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2011-11       Impact factor: 4.086

View more
  7 in total

1.  Metal bridges illuminate transmembrane domain movements during gating of the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  Yassine El Hiani; Paul Linsdell
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

Review 2.  Molecular modelling and molecular dynamics of CFTR.

Authors:  Isabelle Callebaut; Brice Hoffmann; Pierre Lehn; Jean-Paul Mornon
Journal:  Cell Mol Life Sci       Date:  2016-10-07       Impact factor: 9.261

3.  Location of a permeant anion binding site in the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Hussein N Rubaiy; Paul Linsdell
Journal:  J Physiol Sci       Date:  2015-02-12       Impact factor: 2.781

Review 4.  Architecture and functional properties of the CFTR channel pore.

Authors:  Paul Linsdell
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

Review 5.  Structural mechanisms of CFTR function and dysfunction.

Authors:  Tzyh-Chang Hwang; Jiunn-Tyng Yeh; Jingyao Zhang; Ying-Chun Yu; Han-I Yeh; Samantha Destefano
Journal:  J Gen Physiol       Date:  2018-03-26       Impact factor: 4.086

6.  Functional organization of cytoplasmic portals controlling access to the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel pore.

Authors:  Man-Song Li; Elizabeth A Cowley; Yassine El Hiani; Paul Linsdell
Journal:  J Biol Chem       Date:  2018-02-23       Impact factor: 5.157

7.  Modulation of CFTR gating by permeant ions.

Authors:  Han-I Yeh; Jiunn-Tyng Yeh; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2014-12-15       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.